Skye Bioscience, Inc. (SKYE)
NASDAQ: SKYE · Real-Time Price · USD
1.570
+0.040 (2.61%)
At close: Oct 14, 2026, 4:00 PM EDT
1.600
+0.030 (1.91%)
After-hours: Oct 14, 2026, 7:44 PM EDT
Skye Bioscience Market Cap
Skye Bioscience has a market cap or net worth of $6.95 million as of October 14, 2026. It is the 43,657th most valuable company in the world and the 5,871st biggest in the United States. Its market cap has decreased by 85.08% in one year.
Market Cap
6.95M
Enterprise Value
-2.93M
1-Year Change
-85.08%
Global Rank
Country Rank
#5,871 United States
Category
ChartMarket Cap Chart
Since April 11, 2024, Skye Bioscience's market cap has decreased from $356.10M to $6.95M, a decrease of -98.05%. That is a compound annual growth rate of -79.16%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2026 | 7.00M | -70.83% |
| Dec 31, 2025 | 24.00M | -72.06% |
| Dec 31, 2024 | 85.90M | -75.88% |
| Apr 11, 2024 | 356.10M | - |
View and export this data all the way back to 2024. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Soligenix | 7.65M |
| CollPlant Biotechnologies | 7.60M |
| CNS Pharmaceuticals | 7.58M |
| Aprea Therapeutics | 7.47M |
| Exicure | 7.14M |
| Azitra | 7.13M |
| FibroBiologics | 6.96M |
| XTL Biopharmaceuticals | 6.89M |